Table 2 Survival outcomes and hazard models of alternative-DH/TH for event/progression free and overall survival.

From: Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients

  1. Est. estimated, mo. months, EFS/PFS event free survival/progression free survival, OS overall survival, HR hazard ratio, COO cell-of-origin, ABC-like activated B cell-like, Alt-DH/TH alternative-DH/TH.
Back to article page